TOWARDS QUADRUPLE THERAPY FOR HEART FAILURE WITH REDUCED EJECTION FRACTION: DAPA-HF SECONDARY ANALYSIS DATA Article Kobalava Z.D., Medovchshikov V.V., Yeshniyazov N.B. Russian Journal of Cardiology. Silicea-Poligraf. Vol. 25. 2020. P. 71-80
THE INCIDENCE OF CHRONIC HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS Article Yeshniyazov N.B., Medovchshikov V.V., Tereshchenko E.A., Khasanova E.R., Kobalava Z.D. European Journal of Heart Failure. Elsevier Science Publishing Company, Inc.. Vol. 21. 2019. P. 253-253
THE MODERN PARADIGM OF PATHOPHYSIOLOGY, PREVENTION AND TREATMENT OF HEART FAILURE IN TYPE 2 DIABETES MELLITUS Article Kobalava Z.D., Medovchshikov V.V., Yeshniyazov N.B., Khasanova E.R. Russian Journal of Cardiology. Silicea-Poligraf. Vol. 24. 2019. P. 98-111
THE INCIDENCE OF THE FIRST ONSET DIAGNOSED TYPE 2 DIABETES MELLITUS IN PATIENTS WITH CARDIOVASCULAR DISEASES Article Medovchshikov V.V., Yeshniyazov N.B., Tereshchenko E.A., Khasanova E.R., Kobalava Z.D. European Journal of Heart Failure. Elsevier Science Publishing Company, Inc.. Vol. 21. 2019. P. 135-135
TYPE 2 DIABETES MELLITUS AND HEART FAILURE: INNOVATIVE POSSIBILITIES FOR MANAGEMENT OF PROGNOSIS [САХАРНЫЙ ДИАБЕТ 2-ГО ТИПА И СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ: ИННОВАЦИОННЫЕ ВОЗМОЖНОСТИ УПРАВЛЕНИЯ ПРОГНОЗОМ] Article Kobalava Zh.D., Yeshniyazov N.B., Medovchshikov V.V., Khasanova E.R. Kardiologiia. KlinMed Consulting. Vol. 59. 2019. P. 76-87